Liposomal lurtotecan (NX211): Determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 738, Issue 1, 2000, Pages 155-163

  Loos, Walter J ^a   Kehrer, Diederik ^a   Brouwer, Eric ^a   Verweij, Jaap ^a   De Bruijn, Peter ^a   Hamilton, Marta ^b   Gill, Stan ^b   Nooter, Kees ^a   Stoter, Gerrit ^a   Sparreboom, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b GILEAD SCIENCES   (United States)

Author keywords

Lurtotecan

Indexed keywords

LIPOSOME; LURTOTECAN; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; EXTRACTION; FLUORESCENCE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE;

ACETONITRILES; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; PERCHLORIC ACID; SENSITIVITY AND SPECIFICITY;

EID: 0033984541     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(99)00513-7     Document Type: Article

References (25)

1. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.T., Sim G.A. J. Am. Chem. Soc. 88:1966;3888.
2. Takimoto C.H., Arbuck S.G. Chabner B.A., Longo D.L. Cancer Chemotherapy and Biotherapy. 1996;463 Lippencott-Raven.
3. Luzzio M.J., Besterman J.M., Emerson D.L., Evans M.G., Lackey K., Leitner P.L., McIntyre G., Morton B., Myers P.L., Peel M., Sisco J.M., Sternback D.D., Tong W.-Q., Truesdale A., Uehling D.E., Vuong A., Yates J. J. Med. Chem. 38:1995;395.
4. Emerson D.L., Besterman J.M., Brown H.R., Evans M.G., Leitner P.L., Luzzio M.J., Schaffer J.E., Sternbach D.D., Uehling D., Vuong A. Cancer Res. 55:1995;603.
5. Besterman J.M. Ann. NY Acad. Sci. 803:1996;202.
6. Gerrits C.J., Creemers G.J., Schellens J.H.M., Wissel P., Planting A.S.T., Kunka R., Selinger K., de Boer-Dennert M.M., Marijnen Y., Verweij J. Br. J. Cancer. 73:1996;744.
7. Eckhardt S.G., Baker S.D., Eckardt J.R., Burke T.G., Warner D.L., Kuhn J.G., Rodriguez G., Fields S., Thurman A., Smith L., Rothenburg M.L., White L., Wisssel P., Kunka R., DePee S., Littlefield D., Burris H.A., Von Hoff D.D. Clin. Cancer Res. 4:1998;595.
8. Paz-Ares L., Kunka R., DeMaria D., Cassidy J., Alden M., Beranek P., Kaye S., Littlefield D., Reilly D., Depee S., Wissel P., Twelves C., O'Dwyer P. Br. J. Cancer. 78:1998;1329.
9. Herzberg R.P., Caranfa M.J., Holden K.G., Jakas D.R., Gallagher G., Mattern M.R., Mong S.-M., Bartus J.O., Johnson R.K., Kingsbury W.D. J. Med. Chem. 32:1989;715.
10. Burke T.G., Gao X. J. Pharm. Sci. 83:1994;967.
11. Subramanian D., Muller M.T. Oncol. Res. 7:1995;461.
12. Daoud S.S., Fetouh M.I., Giovanella B.C. Anti-Cancer Drugs. 6:1995;83.
13. Jones C.B., Clements M.K., Wasi S., Daoud S.S. Cancer Chemother. Pharmacol. 40:1997;475.
14. Lundberg B.B. Anticancer Drug Des. 13:1998;453.
15. Sadzuka Y., Hirotsu S., Hirota S. Cancer Lett. 15:1998;99.
16. Emerson D.L., Amirgahari N., Bendele R., Brown E., Chen L.-S., Chiang S.-M., Gill S., LeRay J.D., Moynihan K., Tomkinson B., Luzzio M.J. Proc. Am. Assoc. Cancer Res. 39:1998;278. Abstract.
17. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309.
18. Sparreboom A., Loos W.J., Schellens J.H.M., De Bruijn P., Nooter K., Stoter G., Verweij J. Proc. Am. Assoc. Cancer Res. 38:1997;306. Abstract.
19. Selinger K., Smith G., Depee S., Aureche C. J. Pharm. Biomed. Anal. 13:1995;1521.
20. Stafford C.G., St. Claire R.L. J. Chromatogr. B. 663:1995;119.
21. Scholten A.H.M.T., Welling P.L.M., Brinkman U.A.Th., Frei R.W. J. Chromatogr. 199:1980;239.
22. Salamoun J., Frantisek J. J. Chromatogr. 378:1986;173.
23. Schaefer H.G. J. Chromatogr. 616:1993;87.
24. di Pietra A.M., Andrisano V., Gotti R., Cavrini V. J. Pharm. Biomed. Anal. 14:1996;1191.
25. Tse S.Y., Whetsel R. J. Chromatogr. B. 709:1998;127.